Innovent Biologics (01801.HK): Seven innovative products including Xindimei and Xinmeiyue successfully included in the 2026 National Reimbursement Drug List

Zhitong Finance APP News: Innovent Biologics (01801.HK) announced that seven innovative products of Innovent Biologics have been successfully included in the new edition of the National Drug Catalog for Basic Medical Insurance, Maternity Insurance, and Work-Related Injury Insurance (2026).